These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial. Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346 [TBL] [Abstract][Full Text] [Related]
11. Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source - Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial. Toyoda K; Uchiyama S; Hagihara Y; Kuwashiro T; Mori T; Kamiyama K; Urano Y; Taniguchi A; Nozaki K; Cronin L; Grauer C; Brueckmann M; Diener HC Circ J; 2020 Nov; 84(12):2286-2295. PubMed ID: 33132228 [TBL] [Abstract][Full Text] [Related]
12. Review and update of the concept of embolic stroke of undetermined source. Diener HC; Easton JD; Hart RG; Kasner S; Kamel H; Ntaios G Nat Rev Neurol; 2022 Aug; 18(8):455-465. PubMed ID: 35538232 [TBL] [Abstract][Full Text] [Related]
13. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. Diener HC; Sacco RL; Easton JD; Granger CB; Bernstein RA; Uchiyama S; Kreuzer J; Cronin L; Cotton D; Grauer C; Brueckmann M; Chernyatina M; Donnan G; Ferro JM; Grond M; Kallmünzer B; Krupinski J; Lee BC; Lemmens R; Masjuan J; Odinak M; Saver JL; Schellinger PD; Toni D; Toyoda K; N Engl J Med; 2019 May; 380(20):1906-1917. PubMed ID: 31091372 [TBL] [Abstract][Full Text] [Related]
14. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial. Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ; J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG; J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076 [TBL] [Abstract][Full Text] [Related]
16. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial. Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG; Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509 [TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy. Sharma M; Smith EE; Pearce LA; Perera KS; Kasner SE; Yoon BW; Ameriso SF; Puig J; Damgaard D; Fiebach JB; Muir KW; Veltkamp RC; Toni DS; Shamalov N; Gagliardi RJ; Mikulik R; Engelter ST; Bereczki D; O'Donnell MJ; Saad F; Shoamanesh A; Berkowitz SD; Mundl H; Hart RG; Int J Stroke; 2022 Aug; 17(7):799-805. PubMed ID: 34791941 [TBL] [Abstract][Full Text] [Related]
18. Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation. Witte KK; Tsivgoulis G; Reynolds MR; Tsintzos SI; Eggington S; Ismyrloglou E; Lyon J; Huynh M; Egea M; de Brouwer B; Ziegler PD; Franco N; Joglekar R; Rosemas SC; Liu S; Thijs V BMC Cardiovasc Disord; 2021 Mar; 21(1):160. PubMed ID: 33789592 [TBL] [Abstract][Full Text] [Related]
19. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial. Del Brutto VJ; Diener HC; Easton JD; Granger CB; Cronin L; Kleine E; Grauer C; Brueckmann M; Toyoda K; Schellinger PD; Lyrer P; Molina CA; Chutinet A; Bladin CF; Estol CJ; Sacco RL J Am Heart Assoc; 2022 Jun; 11(11):e023545. PubMed ID: 35656979 [TBL] [Abstract][Full Text] [Related]
20. Embolic Stroke of Undetermined Source: Gateway to a New Stroke Entity? Schäbitz WR; Köhrmann M; Schellinger PD; Minnerup J; Fisher M Am J Med; 2020 Jul; 133(7):795-801. PubMed ID: 32247819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]